This study is looking at new ways to use advanced imaging to better understand kidney (renal) cancer. Researchers are using a special type of MRI scan called advanced diffusion imaging, along with an injection of Tc-99m Pentetate (a radioactive tracer) to measure kidney function. The goal is to see if these methods can accurately identify the type of kidney tumor and predict how well your kidneys will work after surgery. They are looking for 39 participants aged 21 to 85 who have a kidney mass and are scheduled for a specific type of surgery called a laparoscopic partial nephrectomy. The main goal is to see how accurately the imaging can predict the tumor type before surgery.

Study design

This study plans to enroll 39 participants. It is an interventional study, meaning participants will receive specific interventions.

What's involved

You would undergo a 1-hour research MRI scan and receive an injection of Tc-99m Pentetate during a 3-5 hour scanning session. This happens about one week before your surgery.

Compensation

Not stated in the trial record.

Follow-up

The primary outcome is measured at baseline, which is one week prior to your operation.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.